The goal of this study is to specify the interventions, implementation strategies and control conditions from the Sickle Cell Disease Implementation Consortium (SCDIC) using a mixed-methods approach to study site materials and conduct semi-structured qualitative interviews with site representatives (N=3 per site).
Ana Baumann, PhD | |
314 935 3585 | |
[email protected] |
Allison King, MD, MPH, PhD | |
3144544291 | |
[email protected] |
35 United States sites
> 18 Years
Observational
All
Behavioral
three representatives of each of the SDIC sites: the Principal Investigator, and two people nominated by the PI.
none